drugset / Trial / NCT03618589
Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy
RandomizedParallel-groupSingle-blindTreatment
Summary
There is no information on the effect of pregabalin in patients with neuropathic pain in cervical myelopathy under routine clinical practice. The investigators will conduct this prospective, randomized trial to determine the efficacy of pregabalin for neuropathic pain in cervical myelopathic patients in order to validate or refute this popular practice. The primary aim of this study was to compare Leeds assessment of neuropathic symptoms and signs scale (LANSS) scores of neuropathic pain in cervical myelopathy patients.
Timeline
- Start
- 2016-11-26
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 300 mg | — |
| Background | Oxycodone | Other / unclassified | 5 mg | — |